FDA: Pancreatic enzyme drugmakers must submit NDA

PBMs, retail chains, and pharmacy schools have all contributed to the current state of the profession. It's time they worked on fixing it.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.

Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.

Despite pleas from celiac disease advocates, the FDA still does not require drug manufacturers to note on the label whether a medication contains gluten.